{
"NDC": {
"NDCCode": "73079-050-30",
"PackageDescription": "1 BOTTLE, PLASTIC in 1 CARTON (73079-050-30) / 30 CAPSULE in 1 BOTTLE, PLASTIC",
"NDC11Code": "73079-0050-30",
"ProductNDC": "73079-050",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Zokinvy",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Lonafarnib",
"DosageFormName": "CAPSULE",
"RouteName": "ORAL",
"StartMarketingDate": "20201120",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA213969",
"LabelerName": "Eiger BioPharmaceuticals, Inc.",
"SubstanceName": "LONAFARNIB",
"StrengthNumber": "50",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Farnesyltransferase Inhibitor [EPC], Farnesyltransferase Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-04-06",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20251231",
"StartMarketingDatePackage": "20201120",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}